Premium
Cytoprotective effects of phenolic acids on methylglyoxal‐induced apoptosis in Neuro‐2A cells
Author(s) -
Huang ShangMing,
Chuang HongChih,
Wu ChiHao,
Yen GowChin
Publication year - 2008
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.200700360
Subject(s) - methylglyoxal , glycation , apoptosis , biochemistry , chemistry , pharmacology , microbiology and biotechnology , biology , receptor , enzyme
In the process of glycation, methylglyoxal is a reactive dicarbonyl compound physiologically generated as an intermediate of glycolysis, and is found in high levels in blood or tissue of diabetic models. Biological glycation has been commonly implicated in the development of diabetic microvascular complications of neuropathy. Increasing evidence suggests that neuronal cell cycle regulatory failure followed by apoptosis is an important mechanism in the development of diabetic neuropathy complication. Naturally occurring antioxidants, especially phenolic acids have been recommended as the major bioactive compounds to prevent chronic diseases and promote health benefits. The objective of this study was to investigate the inhibitory abilities of phenolic acids (chlorogenic acid, syringic acid and vanillic acid) on methylglyoxal‐induced mouse Neuro‐2A neuroblastoma (Neuro‐2A) cell apoptosis in the progression of diabetic neuropathy. The data indicated that methylglyoxal induced mouse Neuro‐2A neuroblastoma (Neuro‐2A) cell apoptosis via alternation of mitochondria membrane potential and Bax/Bcl‐2 ratio, activation of caspase‐3, and cleavage of poly (ADP‐ribose) polymerase. Furthermore, the results demonstrated that activation of mitogen‐activated protein kinase signal pathways (JNK and p38) participated in the methylglyoxal‐induced Neuro‐2A cell apoptosis process. Treatment of Neuro‐2A cells with phenolic acids markedly suppresses cell apoptosis induced by methylglyoxal, suggesting that phenolic acids possess cytoprotective ability in the prevention of diabetic neuropathy complication.